These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 10768158

  • 21. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z, Niezgodzińska-Maciejek A.
    Neurol Neurochir Pol; 2000; 34 Suppl 1():165-75. PubMed ID: 10768156
    [Abstract] [Full Text] [Related]

  • 22. Vigabatrin: 2008 update.
    Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [Abstract] [Full Text] [Related]

  • 23. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy.
    Camfield P, Camfield C.
    Neurology; 2005 Mar 22; 64(6):973-5. PubMed ID: 15781810
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Vigabatrin in childhood epilepsy: a 5-year follow-up study.
    Uldall P, Alving J, Gram L, Høgenhaven H.
    Neuropediatrics; 1995 Oct 22; 26(5):253-6. PubMed ID: 8552215
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B, Fontana E, Vigevano F, Fusco L, Torelli D, Galeone D, Buti D, Cianchetti C, Gnanasakthy A, Iudice A.
    Epilepsia; 1995 Jul 22; 36(7):687-91. PubMed ID: 7555986
    [Abstract] [Full Text] [Related]

  • 37. Vigabatrin and visual field defects in pediatric epilepsy patients.
    You SJ, Ahn H, Ko TS.
    J Korean Med Sci; 2006 Aug 22; 21(4):728-32. PubMed ID: 16891821
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of vigabatrin in the management of infantile epileptic syndromes.
    Appleton RE.
    Neurology; 1993 Nov 22; 43(11 Suppl 5):S21-3. PubMed ID: 8232983
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.